View breaking news headlines for VSAR stock from trusted media outlets at MarketBeat. What's going on at Versartis (NASDAQ:VSAR)? View breaking news headlines for VSAR stock from trusted media outlets at MarketBeat. Sign up Log in . Share on Stocktwits. Print this article. Share by Email. Headlines Versartis (NASDAQ VSAR) News Headlines. What Do Versartis' Troubles Mean For Opko Health? - Benzinga Sep 22, 2017 · As such, Ladenburg reiterated its Buy rating and $16 price target for the shares of Opko Health. At time of writing, shares of Opko Health were rising 0.15 percent to $6.49, but Versartis was Versartis (VSAR) Says Phase 3 VELOCITY Trial of ...
Mar 21, 2020 · Real time Versartis (VSAR) stock price quote, stock graph, news & analysis. Real time Versartis (VSAR) stock price quote, stock graph, news & analysis.
Sep 22, 2017 · As such, Ladenburg reiterated its Buy rating and $16 price target for the shares of Opko Health. At time of writing, shares of Opko Health were rising 0.15 percent to $6.49, but Versartis was Versartis (VSAR) Says Phase 3 VELOCITY Trial of ... Versartis (VSAR) Says Phase 3 VELOCITY Trial of Somavaratan in Pediatric Growth Hormone Deficiency Did Not Meet Primary Endpoint VSAR Versartis, Inc. stock - Finscreener.com Volume Overview; Volume: 349.90K: Shares Outstanding: 36.24M: Trades Count: 596: Dollar Volume: 416.37K: Avg. Volume: 479.43K: Avg. Weekly Volume: 238.86K: Avg U.S. Gold Corp. (USAU) Stock Analysis & News | Seeking Alpha
VSAR seems forming a nice fallen angel formation. We would consider Speculative $2.50 March calls, which are $0.50 now. * Trade Criteria * 1st Found- December 6, 2017 Pattern/Why- Fallen angel Entry Target Criteria- $2.50 March Calls Exit Target Criteria- Momentum Stop Loss Criteria- N/A Indicator Notes- Twiggs Moneyflow accumulation Special Note- Some recent
VSAR Stock Price, Forecast & News (Versartis) | MarketBeat MarketBeat's community ratings are surveys of what our community members think about Versartis and other stocks. Vote "Outperform" if you believe VSAR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VSAR will underperform the S&P 500 over the long term. You may vote once every thirty days. VSAR Stock Quote - Aravive Inc - Bloomberg Markets Stock analysis for Aravive Inc (VSAR) including stock price, stock chart, company news, key statistics, fundamentals and company profile. - VSAR - Stock Price Today - Zacks View %COMPANY_NAME% VSAR investment & stock information. Get the latest %COMPANY_NAME% VSAR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
Sep 22, 2017 · Versartis (VSAR) stock is at record lows, while an FDA warning prompted a negative analyst attention for Intercept Pharmaceuticals (ICPT) stock, 2 Biotech Stocks Tanking; …
Failed hormone drug trial sends Versartis (NASDAQ: VSAR ... Sep 22, 2017 · The Menlo Park company's (NASDAQ: VSAR) twice-a-month drug— called somavaratan, or VRS-317 — is designed to help children with a growth hormone deficiency. Anthera Pharmaceuticals Inc. (ANTH) Stock Quotes | Nasdaq Anthera Pharmaceuticals Inc. (ANTH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Oct 02, 2013 · Years ago I would look at Seeking Alpha but figured the analyses were a bit amateurish, but over time, I think more and more good stuff has been rising to the top. Still, I was curious what others here thought about these aggregators. StockTwits too. I'm not a big follower of StockTwits and thought it was just a way to try to work the Twitter craze, but I see some recognizable
A look at earnings from the view of macro-economists and market technicians Versartis (NASDAQ: VSAR)'s Somavaratan Still Has A Path ... Sep 22, 2017 · Cantor Fitzgerald cut its Versartis Inc (NASDAQ: VSAR) target from $34 to $14 — and was still able to rate it Overweight. The stock dropped from $21.60 to $3.20 in Friday VSAR News Today (Versartis) | MarketBeat View breaking news headlines for VSAR stock from trusted media outlets at MarketBeat. What's going on at Versartis (NASDAQ:VSAR)? View breaking news headlines for VSAR stock from trusted media outlets at MarketBeat. Sign up Log in . Share on Stocktwits. Print this article. Share by Email. Headlines Versartis (NASDAQ VSAR) News Headlines. What Do Versartis' Troubles Mean For Opko Health? - Benzinga